Telmisartan And Amlodipine Tablet
Product Images NDC 0378-1076

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Telmisartan And Amlodipine (NDC 0378-1076). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mylan Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Telmisartan Structural Formula (Ca60a4d5 Ace7 4889 94ee E2265fd63811 05)

Chemical structure of telmisartan, illustrating its molecular framework with multiple aromatic rings and functional groups, consistent with the active ingredient in Telmisartan and Amlodipine tablets.*

FDA Label Image

Figure 1a: Probability Of Achieving Systolic Blood Pressure < 140 Mmhg At Week 8 (Image 01)

A line graph showing the percentage of patients achieving systolic blood pressure (SBP) below 140 mmHg across different baseline SBP values ranging from 140 to 180 mmHg. Four data series are plotted, corresponding to treatments labeled as T80/A10, T80, T80/A10 (with triangles), and placebo, illustrating their comparative effectiveness in lowering SBP.*

FDA Label Image

Figure 1b: Probability Of Achieving Systolic Blood Pressure < 130 Mmhg At Week 8 (Image 02)

A line chart depicting the percentage of patients achieving systolic blood pressure (SBP) less than 130 mmHg over a range of baseline SBP values (140 to 180 mmHg). The graph compares four treatment groups: T80/A10, A10, T80, and placebo, with each group represented by different markers. The percentage achieving target SBP decreases as baseline SBP increases across all groups.*

FDA Label Image

Figure 2a: Probability Of Achieving Diastolic Blood Pressure < 90 Mmhg At Week 8 (Image 03)

A line chart showing the percentage of diastolic blood pressure (DBP) below 90 mmHg at various baseline DBP levels (95-110 mmHg) for different treatments, including T80/A10, A10, T80, and Placebo. The x-axis represents baseline DBP in mmHg, and the y-axis shows the percentage with DBP below 90 mmHg. Four treatment groups are indicated with different markers.*

FDA Label Image

Figure 2b: Probability Of Achieving Diastolic Blood Pressure < 80 Mmhg At Week 8 (Image 04)

A scatter plot graph displaying the percentage of diastolic blood pressure (DBP) less than 80 mmHg versus baseline DBP values ranging from 95 to 110 mmHg. The graph compares four treatment groups labeled as T80/A10, A10, T80, and Placebo, each represented by different symbols. The percentage of patients achieving DBP below 80 mmHg decreases as baseline DBP increases for all treatments except placebo, which remains near zero across the range.*

FDA Label Image

Telmisartan And Amlodipine Tablets 40 mg/5 mg Bottle Label (Image 05)

Label for Telmisartan and Amlodipine Tablets, USP 40 mg/5 mg by Mylan Pharmaceuticals Inc. The label includes dosage instructions, storage conditions, and a child-resistant container warning. It also shows the NDC 0378-1075-93 and a bar code, with package size of 30 tablets.*

FDA Label Image

Telmisartan And Amlodipine Tablets 40 mg/10 mg Bottle Label (Image 06)

Label for Telmisartan and Amlodipine Tablets, USP 40 mg/10 mg by Mylan Pharmaceuticals Inc. The package contains 30 oral tablets. Instructions include storing at 20° to 25°C (68° to 77°F), keeping medication out of reach of children, and using a child-resistant container with a tight closure. The label also cautions not to remove tablets from the bottle until immediately before administration.*

FDA Label Image

Telmisartan And Amlodipine Tablets 80 mg/5 mg Bottle Label (Image 07)

Label for Telmisartan and Amlodipine Tablets USP 80 mg/5 mg oral tablets by Mylan Pharmaceuticals Inc. The label states the strength as 80 mg of telmisartan and 5 mg of amlodipine per tablet, with a 30-tablet count. Storage instructions and dosage information disclaimers are included, noting the tablets should be stored at 20° to 25°C and kept out of children's reach.*

FDA Label Image

Telmisartan And Amlodipine Tablets 80 mg/10 mg Bottle Label (Image 08)

Packaging label for Telmisartan and Amlodipine Tablets, USP with a strength of 80 mg/10 mg. The label indicates the product is manufactured by Mylan Pharmaceuticals Inc. and contains 30 tablets. It includes dosage instructions, storage conditions, and a warning to keep the medication out of reach of children. The label also features a barcode and regulatory information.*

FDA Label Image

Amlodipine Besylate Structural Formula (Image 09)

Chemical structure diagram of telmisartan, depicting its molecular components and an asymmetric carbon center, accompanied by a sulfonic acid group attached to a benzene ring.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.